Faropenem promising antituberculosis candidate competing with ethambutol in efficacy Dr. Shravani Dali13 Jun 2023 11:00 AM ISTFaropenem rivals ethambutol in efficacy, with fewer side effects for First-line TB treatment suggests a new study published in the International...
Faropenem: A Breakthrough in the Fight against Community-Acquired Pneumonia and Drug-Resistant Respiratory Tract Infections Pathogens Dr. Kamal Kant Kohli6 Jun 2023 11:30 AM ISTCommunity-Acquired Pneumonia Epidemiology: Global and Indian Overview: Community-Acquired Pneumonia (CAP) is a leading cause of morbidity and...
Urinary Tract Infection and Role of Antibiotic Faropenem Dr. Kamal Kant Kohli29 Sept 2022 12:30 PM ISTUrinary Tract Infections (UTIs) are among the most common infectious diseases encountered globally, posing a significant clinical and economic burden...
Understanding the scope of Faropenem in Lower Respiratory Tract Infections(LRTIs) Dr. Kamal Kant Kohli1 Jun 2022 11:03 AM ISTLower Respiratory Infections(LRIs): Complexities in the Indian ContextIn India, the burden of lower respiratory tract infections (LRTIs) is...
Faropenem: Decoding the Therapeutic Potential in Acute Bacterial Sinusitis Dr. Kamal Kant Kohli3 Feb 2022 12:30 PM ISTBacterial Sinusitis in Indian Practice SettingsAcute bacterial sinusitis (ABS) - defined as inflammation or infection of the mucosa of the nasal...
